Kathryn J. Moore, Ph.D., FAHA, named the American Heart Association’s 2021 Distinguished Scientist in Arteriosclerosis, Thrombosis and Vascular Biology

Embargoed until 7 a.m. CT / 8 a.m. ET Wednesday, Nov. 3, 2021

(NewMediaWire) – November 03, 2021 – DALLAS – The American Heart Association is presenting its 2021 Distinguished Scientist in Arteriosclerosis, Thrombosis and Vascular Biology to Kathryn J. Moore, Ph.D., FAHA, of New York University Grossman School of Medicine. The Association designates Distinguished Scientist awards in several categories to members who have significantly advanced the understanding of cardiovascular, stroke or brain health. The six 2021 Distinguished Scientist awardees will be recognized during the Association’s Scientific Sessions 2021, which will be fully virtual, Saturday, Nov. 13 through Monday, Nov. 15, 2021.

Dr. Moore’s groundbreaking work has helped to identify new therapeutic targets for the treatment of arteriosclerosis. Throughout her career she has explored how the immune system affects arteriosclerosis and, more recently, the links between myocardial infarction and cancer progression. She is internationally recognized for her research on the molecular pathogenesis of cardiometabolic diseases, and the roles that non-coding RNAs and dysregulated immune responses play in those settings. By forging new links between lipids, metabolism and innate immunity, her discoveries have revealed fundamental insights into pathways that regulate cholesterol homeostasis and vascular inflammation.

“Congratulations to Dr. Moore for her incredible research contributions that have helped forge new paths in our understanding of the biological origins of cardiovascular and cardiometabolic disease,” said Association President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA.

Dr. Moore is the Jean and David Blechman Professor of Cardiology, professor in the department of cell biology and the director of the Cardiovascular Research Center at New York University Grossman School of Medicine in New York City. She also leads The Kathryn Moore Lab at NYU, focused on identifying molecular mechanisms that underpin metabolic dysregulation and chronic inflammation in cardiometabolic diseases and integrating basic science discovery, preclinical and translational research in the areas of noncoding RNA biology, innate immunity and lipid metabolism.

Dr. Moore earned her Ph.D. from McGill University in Montreal, Canada. Her early research focused on the immune response to pathogens, and she became fascinated with the mechanisms of “sterile” inflammation and pursued postdoctoral training at Harvard Medical School in the areas of autoimmunity and atherosclerosis. She joined the Harvard Medical School faculty as an assistant professor in 2001, before moving to New York University in 2009.

Dr. Moore has been the recipient of numerous awards for her contributions in the fields of innate immunity and vascular biology, including the AHA’s Special Recognition Award, the Jeffrey Hoeg Arteriosclerosis Award for Basic Science and Clinical Research, and the National Institute of Health’s Outstanding Investigator Award. In addition, Dr. Moore was recently elected to the National Academy of Sciences.

Additional Resources:

The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here

The American Heart Association’s Scientific Sessions 2021 is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science for health care professionals worldwide. The three-day meeting will feature more than 500 sessions focused on breakthrough cardiovascular basic, clinical and population science updates in a fully virtual experience Saturday, Nov. 13 through Monday, Nov. 15, 2021. Thousands of leading physicians, scientists, cardiologists, advanced practice nurses and allied health care professionals from around the world will convene virtually to participate in basic, clinical and population science presentations, discussions and curricula that can shape the future of cardiovascular science and medicine, including prevention and quality improvement. During the three-day meeting, attendees receive exclusive access to more than 4,000 original research presentations and can earn Continuing Medical Education (CME), Continuing Education (CE) or Maintenance of Certification (MOC) credits for educational sessions. Engage in Scientific Sessions 2021 on social media via #AHA21.

About the American Heart Association

The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.


For Media Inquiries:

AHA News Media in Dallas: 214-706-1173; ahacommunications@heart.org

Michelle Kirkwood: 703-457-7838; michelle.kirkwood@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org